Zirconium nitride (ZrN) nanoparticles (NPs) can offer
appealing
plasmonic properties for biomedical applications, but the synthesis
of nontoxic, water-dispersible nanoformulations exhibiting plasmonic
features in the biotransparency window presents a great challenge.
Here, we report the synthesis, by methods of laser ablation, of small
ZrN-based NPs, which are unique in combining photothermal heating
and near-field enhancement in the transparency window. Depending on
the synthesis environment, the formed ZrN-based NPs exhibit plasmonic
absorption bands with maxima around 660–670 and 610–630
nm, which are largely red-shifted compared to what is expected from
pure ZrN NPs. The observed shift is explained by the inclusion of
zirconium oxide ZrO
x
(1 < x < 2) into NP composition and NP coating by naturally formed ZrO
x
. We then explored biophotonic applications
of ZrN NPs. While pure NPs demonstrate their nontoxicity in vitro,
their conjugation with anti-HER1 affibody ZHER1:1907 and
subsequent photothermal heating with NIR-I laser cause 100% cancer
cell death. In addition, profiting from the field enhancement, we
demonstrate bioimaging functionality using a designed surface-enhanced
Raman scattering probe based on an NP-conjugated azobenzene-CN-OH
molecule as a Raman reporter. Combining a strong photothermal effect
and the imaging option, laser-synthesized ZrN/ZrO
x
NPs promise a major advancement of theranostic modalities
based on plasmonic nanomaterials.